A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ddI

Search Conditions:
Search Keyword : ddI
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ddI
Appearance Frequency: 629 time(s)
Long forms: 12

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
didanosine
(404 times)
Acquired Immunodeficiency Syndrome
(138 times)
ZDV (84 times)
HIV (60 times)
HIV-1 (39 times)
1990 Advances in the management of HIV disease: focus on didanosine (ddI). A symposium. Houston, Texas, 18 September 1989. Proceedings.
2',3'-dideoxyinosine
(211 times)
Pharmacology
(50 times)
AZT (63 times)
ddC (50 times)
HIV (45 times)
1987 Application of high-performance liquid chromatography and thermospray high-performance liquid chromatography-mass spectrometry to the analysis and identification of 2',3'-dideoxyadenosine and its metabolite in biological media.
drug didanosine
(4 times)
Pharmacology
(1 time)
AIDS (1 time)
AZT (1 time)
CMC (1 time)
1995 Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
dideoxynucleoside drug is 2',3'-dideoxyinosine
(2 times)
Allergy and Immunology
(2 times)
AIDS (2 times)
CFU-GM (2 times)
IL-3 (1 time)
1993 Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
2',3'-dideoxyribosylhypoxanthine
(1 time)
Biochemistry
(1 time)
AZT (1 time)
AZU (1 time)
ddA (1 time)
1991 1H NMR study of the sugar pucker of 2',3'-dideoxynucleosides with anti-human immunodeficiency virus (HIV) activity.
3'-azido-3'-deoxythymidine, 2',3'-dideoxyinosine
(1 time)
Anti-Bacterial Agents
(1 time)
DFC (1 time)
DOT (1 time)
HIV-1 (1 time)
2011 Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase.
decline in patients receiving didanosine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
NVP (1 time)
2004 Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
dermal dose of 2',3'-dideoxyinosine
(1 time)
Pharmacology
(1 time)
--- 1995 Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.
distribution in tissue of 2',3'-dideoxyinosine
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1996 Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine.
10  drug dideoxyinosine
(1 time)
Toxicology
(1 time)
--- 1992 Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine.
11  drugs, II: Effect of 2',3'-dideoxyinosine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HPLC (1 time)
1992 Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
12  once-daily didanosine
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
TAD (1 time)
1999 Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team.